How many studies have been conducted on Bifidobacterium%20longum?

BiohacksAI has indexed 300 PubMed studies on Bifidobacterium%20longum, including 13 randomized controlled trials (RCTs). 15% of studies involve human subjects.

What are the main research areas for Bifidobacterium%20longum?

The primary research domains for Bifidobacterium%20longum are 🦠 Gut & Microbiome, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Bifidobacterium%20longum

A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It inhibits the growth of pathogenic bacteria, may modulate the immune response, and is used as a PROBIOTIC.

300+ PubMed studies analyzed · 13 RCTs · Evidence Score: 44.7

Research Domains

Bifidobacterium%20longum has been studied across 17 research domains including 🦠 Gut & Microbiome, 🔬 Inflammation, 🛡️ Immunity, 🧘 Stress & Anxiety, 🔬 Oncology. The primary research focus is 🦠 Gut & Microbiome with 83% of studies addressing this area.

Loading evidence profile...

This evidence profile for Bifidobacterium%20longum is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.